⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002066784

Botwood Nicholas A.J.

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

10

Companies

1

Filings

3

CIK

0002066784

Forms 4 and 5

Insider transactions

10 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-12	SNDXSyndax Pharmaceuticals IncS Sale	Head of R&D, CMO	SSale	−31.2K sh	$18.14	−$567K	60,885
2026-06-12	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Head of R&D, CMO	MExercise/Conversion	+31.2K sh	$13.82	+$432K	92,120
2026-06-12	SNDXSyndax Pharmaceuticals Inc · Stock options (Right to buy)M Exercise/Conversion	Head of R&D, CMO	MExercise/Conversion	+31.2K sh	—	—	0
2026-06-11	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Head of R&D, CMO	MExercise/Conversion	+22.5K sh	$13.82	+$311K	95,165
2026-06-11	SNDXSyndax Pharmaceuticals IncS Sale	Head of R&D, CMO	SSale	−34.3K sh	$18.00	−$617K	60,885
2026-06-11	SNDXSyndax Pharmaceuticals Inc · Stock options (Right to buy)M Exercise/Conversion	Head of R&D, CMO	MExercise/Conversion	+22.5K sh	—	—	0
2026-02-04	SNDXSyndax Pharmaceuticals IncA Award	Head of R&D, CMO	AAward	+24K sh	—	—	59,165
2026-02-04	SNDXSyndax Pharmaceuticals IncA Award	Head of R&D, CMO	AAward	+36K sh	—	—	95,165
2026-02-04	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)A Award	Head of R&D, CMO	AAward	+145K sh	$20.43	+$2.96M	144,700
2025-05-16	SNDXSyndax Pharmaceuticals IncP Purchase	Head of R&D, CMO	PPurchase	+11.8K sh	$8.99	+$106K	35,165

Recent filings

3

Accepted (ET)
Jun 124
Botwood Nicholas A.J.0001193125-26-269694
SEC(opens sec.gov)
Feb 64
Botwood Nicholas A.J.0001193125-26-041334
SEC(opens sec.gov)
May 194
Botwood Nicholas A.J.0000950170-25-074301
SEC(opens sec.gov)

Companies

1

Syndax Pharmaceuticals IncHead of R&D, CMOSNDX

Address

730 THIRD AVENUE FLOOR 9

NEW YORK, NY, 10017